Interesting thanks - nothing about projected numbers here, and it's pretty vague, but I like that they're looking to make a number of acquisitions. Maybe taking that route makes them a more attractive partner to companies like Merck.
They mention "several strategic acquisitions." The next few questions there would presumably be how many and what would be the cost? They have the $7 mil in financing - is that enough? Or would there be a share offering?